<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="578">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05153629</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-62416</org_study_id>
    <nct_id>NCT05153629</nct_id>
  </id_info>
  <brief_title>Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy</brief_title>
  <official_title>Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a&#xD;
      pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The&#xD;
      primary aim for the investigators is to determine if use of a TENS unit will reduce&#xD;
      post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to&#xD;
      assess if it can help minimize narcotic use.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain on 11-point Visual Analog Score scale for each day until Ureteral Stent removed</measure>
    <time_frame>3-10 days</time_frame>
    <description>VAS is a validated tool widely used to assess pain intensity. Possible scores range from 0 (no pain) to 10 (worst possible pain)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Ureteral Calculi</condition>
  <condition>Nephrolithiasis</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will follow standard care until the ureteral stent is removed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TENS device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will use the TENS device until the ureteral stent is removed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS</intervention_name>
    <description>TENS device used four times a day for 60 minutes each time</description>
    <arm_group_label>TENS device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing standard of care ureteroscopy and laser lithotripsy for&#xD;
             urinary stone disease&#xD;
&#xD;
          -  Patients receiving a stent following their ureteroscopy and laser lithotripsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Patients unable to answer pain questionnaire&#xD;
&#xD;
          -  Patients undergoing PCNL&#xD;
&#xD;
          -  Patients being treated for Urologic malignancy with ureteroscopy&#xD;
&#xD;
          -  Patients who require long term or chronic ureteral stent management&#xD;
&#xD;
          -  Patient with implantable stimulators&#xD;
&#xD;
          -  Patient with epilepsy&#xD;
&#xD;
          -  Patients undergoing laser lithotripsy without stent placement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Conti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Conti</last_name>
    <phone>(650) 723-3391</phone>
    <email>sconti@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Simon Conti, MD</last_name>
      <phone>650-723-3391</phone>
      <email>sconti@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>November 28, 2021</last_update_submitted>
  <last_update_submitted_qc>November 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Simon Conti</investigator_full_name>
    <investigator_title>Clinical Assistant Professor, Urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

